packageAbiraterone

abiraterone

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Abiraterone is an anticancer medicine used to treat prostate cancer. It is authorised in the European Union and widely used as an endocrine cancer therapy.

Summary written by glm-5.3-flash from Wikidata Q321431 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:abiraterone
ATC codes:L02BX03
DrugBank:DB05812
PubChem CID:132971
ChEBI:68642
Wikidata:Q321431
formula:C24H31NO
molar mass:349.518 g/mol (PubChem CID 132971)
logP:4.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown